<DOC>
	<DOCNO>NCT03047005</DOCNO>
	<brief_summary>This study test effectiveness relative efficacy naltrexone/bupropion medication maintenance therapy treatment binge eat disorder ( BED ) patient obesity . This controlled test whether , amongst responder acute treatment , naltrexone/bupropion medication result superior maintenance longer-term outcome compare placebo .</brief_summary>
	<brief_title>Behavioral Pharmacologic Treatment Binge Eating Obesity : Maintenance Therapy</brief_title>
	<detailed_description>Binge eat disorder ( BED ) , prevalent formal eating disorder , associate strongly obesity bio-psychosocial impairment . Improved treatment patient obesity BED need produce sustain clinical outcome promote weight loss . This study ( maintenance stage ) RCT provide new novel finding control test , amongst responder acute treatment , whether NB medication result superior maintenance longer-term outcome placebo . This first controlled test maintenance pharmacotherapy BED third RCT BED medication follow-up medication discontinuation .</detailed_description>
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Feeding Eating Disorders</mesh_term>
	<mesh_term>Binge-Eating Disorder</mesh_term>
	<mesh_term>Bulimia</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<criteria>Participated acute treatment bingeeating disorder obesity ; Had positive response acute treatment ; Available duration treatment followup ( 20 month ) ; Read , comprehend , write English sufficient level complete studyrelated material ; Able travel study location ( New Haven , CT ) monthly visit . Currently take antidepressant medication ; Currently take opioid pain medication drug ; Currently take medication influence eating/weight ; History seizures ; Current substance use disorder severe psychiatric disturbance ( e.g. , suicidality ) ; Past current anorexia nervosa , bulimia nervosa ; Pregnant breastfeeding ; Medical status judge study physician contraindication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>